Operating Income (Loss) in USD of Sana Biotechnology, Inc. from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Sana Biotechnology, Inc. quarterly/annual Operating Income (Loss) history and change rate from 2019 to Q3 2025.
  • Sana Biotechnology, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$43.5M, a 29.5% increase year-over-year.
  • Sana Biotechnology, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$240M, a 23.2% increase year-over-year.
  • Sana Biotechnology, Inc. annual Operating Income (Loss) for 2024 was -$273M, a 6.97% increase from 2023.
  • Sana Biotechnology, Inc. annual Operating Income (Loss) for 2023 was -$293M, a 7.55% decline from 2022.
  • Sana Biotechnology, Inc. annual Operating Income (Loss) for 2022 was -$273M, a 23.6% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Sana Biotechnology, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$240M -$43.5M +$18.2M +29.5% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 -$258M -$95M -$45.6M -92.4% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 -$213M -$50.6M +$60.1M +54.3% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$273M -$50.9M +$39.8M +43.9% 01 Oct 2024 31 Dec 2024 10-K 17 Mar 2025
Q3 2024 -$312M -$61.8M -$59.6M -2732% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 -$253M -$49.4M +$66.9M +57.5% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 -$320M -$111M -$26.7M -31.7% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$293M -$90.6M -$8.83M -10.8% 01 Oct 2023 31 Dec 2023 10-K 17 Mar 2025
Q3 2023 -$284M -$2.18M +$84M +97.5% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024
Q2 2023 -$368M -$116M -$43.4M -59.5% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$325M -$84.1M -$52.4M -165% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024
Q4 2022 -$273M -$81.8M +$29.5M +26.5% 01 Oct 2022 31 Dec 2022 10-K 17 Mar 2025
Q3 2022 -$302M -$86.2M -$2.76M -3.3% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023
Q2 2022 -$299M -$72.9M -$91.5M -493% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 -$208M -$31.7M +$149M +82.5% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023
Q4 2021 -$357M -$111M +$2.05M +1.81% 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024
Q3 2021 -$359M -$83.4M -$31.8M -61.6% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 -$327M $18.6M +$106M 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 -$434M -$181M -$147M -443% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 -$286M -$113M 01 Oct 2020 31 Dec 2020 10-K 16 Mar 2023
Q3 2020 -$51.6M 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 -$87.9M 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 -$33.3M 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021

Sana Biotechnology, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$273M +$20.4M +6.97% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025
2023 -$293M -$20.6M -7.55% 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025
2022 -$273M +$84.3M +23.6% 01 Jan 2022 31 Dec 2022 10-K 17 Mar 2025
2021 -$357M -$70.8M -24.7% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024
2020 -$286M -$145M -103% 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2023
2019 -$141M 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.